TECTONIC THERAPEUTIC, INC. Interest Receivable, Current
TECTONIC THERAPEUTIC, INC. (TECX) had Interest Receivable, Current of $4.00 thousand as of 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › and Others
us-gaap:InterestReceivableCurrent · last filed 2022-03-17
- 2020-12-31: Interest Receivable, Current $4.00K.
- 2020-06-30: Interest Receivable, Current $7.00K.
- 2020-03-31: Interest Receivable, Current $149.00K.
- 2019-12-31: Interest Receivable, Current $224.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2020-12-31 | $4.00K 10-K · filed 2022-03-17 |
| 2020-06-30 | $7.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $149.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $224.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $314.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $163.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $220.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |